Mehellou, Youcef ORCID: https://orcid.org/0000-0001-5720-8513 2016. The ProTides boom. Chemmedchem 11 (11) , pp. 1114-1116. 10.1002/cmdc.201600156 |
Preview |
PDF
- Accepted Post-Print Version
Download (424kB) | Preview |
Abstract
The masking of nucleoside phosphate and phosphonate groups by an aryl motif and an amino acid ester, nowadays known as the ‘ProTide’ technology, has proven to be effective in the discovery of nucleotide therapeutics. Indeed, this technology, which was invented by Chris McGuigan in the early 1990s, has inspired the discovery of two FDA-approved antiviral nucleotide drugs, and many more are currently undergoing (pre)clinical development. The usefulness of this technology in the discovery of nucleotide therapeutics is showcased in this Highlight by discussing the ProTides development and the various ProTides that have reached clinical trials.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Pharmacy |
Publisher: | Wiley |
ISSN: | 1860-7179 |
Date of First Compliant Deposit: | 13 March 2017 |
Date of Acceptance: | 7 April 2016 |
Last Modified: | 05 May 2023 00:35 |
URI: | https://orca.cardiff.ac.uk/id/eprint/97271 |
Citation Data
Cited 35 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |